[144] CREXENDO INC SEC Filing

Rhea-AI Filing Summary

Rule 144 notice from Crexendo, Inc. (CXDO) reporting a proposed sale of 3,200 common shares to occur on 08/07/2025 through Muriel Siebert & Co., Inc. The shares were acquired on 03/17/2022 as vested restricted stock units and are being sold under equity compensation payment terms. The filing lists 30,169,531 shares outstanding and an aggregate market value of $20,829.00 for the 3,200 shares. The notice also discloses three prior common share sales by Jeffrey G. Korn in July 2025 totaling 6,800 shares for gross proceeds of $44,113.00. The filer certifies no undisclosed material adverse information.

Insights

Securities Analyst

TL;DR: Routine insider Rule 144 sale of vested RSUs; disclosed prior July sales; limited market impact relative to shares outstanding.

The filing documents a Rule 144 notification for 3,200 Crexendo common shares acquired via RSU vesting on 03/17/2022 and planned for sale on 08/07/2025 through Muriel Siebert. Recent July 2025 dispositions by the same individual total 6,800 shares for gross proceeds of $44,113, indicating ongoing monetization of vested equity rather than an undisclosed event. Given the issuer's stated 30,169,531 shares outstanding, the reported transactions represent a small fraction of the float and are unlikely to materially affect valuation absent other undisclosed activity.

Compliance/Risk Analyst

TL;DR: Filing appears procedurally complete and includes required certification; no red flags in stated disclosures.

The notice includes required seller certification regarding absence of undisclosed material adverse information and identifies acquisition details, payment nature (equity compensation), broker name, dates, and prior sales within three months. From a compliance perspective the submission contains the key elements expected in a Form 144 notice. No express indications of noncompliance are present in the provided text.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Muriel Siebert & Co., Inc., 653 Collins Ave, Miami Beach FL 33139	3200	20829.00	30169531	08/07/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common Stock	03/17/2022	Vesting of RSUs	Issuer			3200	03/17/2022	Equity Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Korn Jeffrey G 4302 Bamford Dr Austin TX 78731	Common	07/02/2025	2800	18211.00
Korn Jeffrey G 4302 Bamford Dr Austin TX 78731	Common	07/03/2025	3000	19436.00
Korn Jeffrey G 4302 Bamford Dr Austin TX 78731	Common	07/07/2025	1000	6466.00

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the Crexendo (CXDO) Form 144 disclose about the proposed sale?

The filing discloses a proposed sale of 3,200 common shares on 08/07/2025 through Muriel Siebert & Co., acquired on 03/17/2022 via RSU vesting.

Who is the seller named in the Form 144 for CXDO?

The prior sales listed identify Jeffrey G. Korn at 4302 Bamford Dr, Austin TX, and the current notice pertains to shares for sale on his account.

How many shares has the seller sold in the past three months according to the filing?

The filing reports three sales in July 2025 totaling 6,800 common shares for gross proceeds of $44,113.00.

How many Crexendo shares are outstanding as stated in the Form 144?

The notice lists 30,169,531 shares outstanding.

What was the acquisition method and payment nature for the shares to be sold?

The 3,200 shares were acquired on 03/17/2022 through RSU vesting and the nature of payment is listed as equity compensation.